DURAGESIC-100
LOE ApproachingNDATRANSDERMALFILM, EXTENDED RELEASE
Approved
Aug 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 8h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DURAGESIC-100 is a transdermal extended-release film formulation approved in 1990 for chronic pain management. The product delivers medication through the skin over an extended period, providing sustained therapeutic levels. Generic name and mechanism of action are not publicly detailed in available data.
LOE Approaching
As a product approaching loss of exclusivity with moderate competitive pressure (30%), brand teams face declining revenue trajectory and likelihood of smaller commercial footprint post-LOE.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
DURAGESIC-100 represents a late-stage career opportunity best suited for professionals focused on defensive commercial strategies and managed care negotiation rather than growth or launch activities. Positions on this team are likely smaller and more specialized, concentrating on market share retention and cost-efficient portfolio management.
Brand ManagerField Sales Representative
Worked on DURAGESIC-100 at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.